Join
Live feed
·
INSIDERFilingvia Quantisnow
LENZ Therapeutics Inc. logo

President, CEO and Secretary Schimmelpennink Evert B. exercised 4,200 shares at a strike of $1.04, increasing direct ownership by 9% to 49,200 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LENZ (LENZ Therapeutics Inc.) and more on Quantisnow.